Skip to main content
Top
Published in: The European Journal of Health Economics 4/2006

01-12-2006 | Original Papers

Economic cost associated with type II diabetes in Spanish patients

Authors: Miguel Ballesta, Florentino Carral, Gabriel Olveira, José Antonio Girón, Manuel Aguilar

Published in: The European Journal of Health Economics | Issue 4/2006

Login to get access

Abstract

An observational descriptive study was carried out of the healthcare resources consumed during 1 year by a sample of patients with type II diabetes of a healthcare area in southern Spain. A total of 517 patients with a mean duration of disease of 9.7±8 years were assessed. A total annual health cost of €4,278/patient was calculated (direct €2,504; indirect €1,774). Multiple regression analysis showed an independent association between total costs and obesity, male sex, number of hospitalizations related to diabetes, permanent disability, macrovascular complications, and both micro- and macrovascular complications. Our findings confirm both the high economic cost associated with type II diabetes and the direct relationship between the costs of the disease and the presence of obesity, male sex, hospitalizations related to diabetes, permanent disability and chronic complications.
Literature
1.
go back to reference King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414–1431PubMed King H, Aubert RE, Herman WH (1998) Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 21: 1414–1431PubMed
2.
go back to reference Carral F, Olveira G, Ramos I et al. (2000) Calidad de vida en pacientes con diabetes mellitus tipo 2 ingresados en un hospital de tercer nivel. Endocrinol Nutr 47: 24–28 Carral F, Olveira G, Ramos I et al. (2000) Calidad de vida en pacientes con diabetes mellitus tipo 2 ingresados en un hospital de tercer nivel. Endocrinol Nutr 47: 24–28
3.
go back to reference Eiser C, Tooke JE (1993) Quality-of-life evaluation in diabetes. Pharmacoeconomics 4: 85–91PubMed Eiser C, Tooke JE (1993) Quality-of-life evaluation in diabetes. Pharmacoeconomics 4: 85–91PubMed
4.
go back to reference Rubin RJ, Altman WM, Mendelson DN (1994) Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78: 809A-809FCrossRefPubMed Rubin RJ, Altman WM, Mendelson DN (1994) Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab 78: 809A-809FCrossRefPubMed
5.
go back to reference American Diabetes Association (2003) Economic costs of diabetes in the United States in 2002. Diabetes Care 26: 917–932PubMed American Diabetes Association (2003) Economic costs of diabetes in the United States in 2002. Diabetes Care 26: 917–932PubMed
6.
go back to reference American Diabetes Association (1998) Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care 21: 296–309PubMed American Diabetes Association (1998) Economic consequences of diabetes mellitus in the United States in 1997. Diabetes Care 21: 296–309PubMed
7.
go back to reference Kangas T, Aro S, Koivisto VA et al. (1996) Structure and costs of health care of diabetic patients in Finland. Diabetes Care 19: 494–497PubMed Kangas T, Aro S, Koivisto VA et al. (1996) Structure and costs of health care of diabetic patients in Finland. Diabetes Care 19: 494–497PubMed
8.
go back to reference Gisbert R, Brosa M (1998) Costes sanitarios y evaluación económica. SOIKOS: Barcelona Gisbert R, Brosa M (1998) Costes sanitarios y evaluación económica. SOIKOS: Barcelona
9.
go back to reference Mata M, Antoñanzas F, Tafalla M, Sanz P (2002) El coste de la diabetes tipo 2 en España. El estudio CODE-2. Gac Sanit 16: 511–520PubMed Mata M, Antoñanzas F, Tafalla M, Sanz P (2002) El coste de la diabetes tipo 2 en España. El estudio CODE-2. Gac Sanit 16: 511–520PubMed
10.
go back to reference Krosnick A (1988) Economic impact of type II diabetes mellitus. Prim Care 15: 423–432PubMed Krosnick A (1988) Economic impact of type II diabetes mellitus. Prim Care 15: 423–432PubMed
11.
go back to reference Henriksson F, Jönsson B (1998) Diabetes: the cost of illness in Sweden. J Intern Med 244: 461–468CrossRefPubMed Henriksson F, Jönsson B (1998) Diabetes: the cost of illness in Sweden. J Intern Med 244: 461–468CrossRefPubMed
12.
go back to reference Norlund A, Apelqvist J, Bitzén O et al. (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250: 57–65CrossRefPubMed Norlund A, Apelqvist J, Bitzén O et al. (2001) Cost of illness of adult diabetes mellitus underestimated if comorbidity is not considered. J Intern Med 250: 57–65CrossRefPubMed
13.
go back to reference Persson U (1995) The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 8 [Suppl 1]: 28–32 Persson U (1995) The indirect costs of morbidity in type II diabetic patients. Pharmacoeconomics 8 [Suppl 1]: 28–32
14.
go back to reference Peisker P (1999) Vademecum Internacional 40 Edición. Medicom: Madrid Peisker P (1999) Vademecum Internacional 40 Edición. Medicom: Madrid
15.
go back to reference Anonymous (2000) Consejería de Salud del Gobierno Canario. Memoria estadística Anonymous (2000) Consejería de Salud del Gobierno Canario. Memoria estadística
16.
go back to reference García F, Molins G, Farre J et al. (1995) La contabilidad de coste en atención primaria: cartera de servicios. Aten Primaria 16: 141–145PubMed García F, Molins G, Farre J et al. (1995) La contabilidad de coste en atención primaria: cartera de servicios. Aten Primaria 16: 141–145PubMed
17.
go back to reference Carral F, Olveira G, Salas J et al. (2002) Estimate of care resource utilization incurred by diabetic patients in a Spanish hospital. Diab Res Clin Pract 56: 27–34CrossRef Carral F, Olveira G, Salas J et al. (2002) Estimate of care resource utilization incurred by diabetic patients in a Spanish hospital. Diab Res Clin Pract 56: 27–34CrossRef
18.
go back to reference Ministerio de Trabajo y Asuntos Sociales (2000) Encuesta de salarios ESA-14. Ministerio de Trabajo y Asuntos Sociales: Madrid Ministerio de Trabajo y Asuntos Sociales (2000) Encuesta de salarios ESA-14. Ministerio de Trabajo y Asuntos Sociales: Madrid
19.
go back to reference Anonymous (nd) Pensiones contributivas del Sistema de Seguridad Social. Ministerio de trabajo y asuntos sociales: Madrid Anonymous (nd) Pensiones contributivas del Sistema de Seguridad Social. Ministerio de trabajo y asuntos sociales: Madrid
20.
go back to reference Brandle M, Zhou H, Smith BRK et al. (2003) The direct medical cost of type 2 diabetes. Diabetes Care 26: 2300–2304PubMed Brandle M, Zhou H, Smith BRK et al. (2003) The direct medical cost of type 2 diabetes. Diabetes Care 26: 2300–2304PubMed
21.
go back to reference Redekop WK, Koopmanschap MA, Rutten GE et al. (2002) Resource consumption and costs in Dutch patients with type 2 diabetes mellitus: results from 29 general practices. Diabet Med 19: 246–253CrossRefPubMed Redekop WK, Koopmanschap MA, Rutten GE et al. (2002) Resource consumption and costs in Dutch patients with type 2 diabetes mellitus: results from 29 general practices. Diabet Med 19: 246–253CrossRefPubMed
22.
go back to reference Jonsson B, CODE-2 Advisory Board (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45: S5–12CrossRefPubMed Jonsson B, CODE-2 Advisory Board (2002) Revealing the cost of type II diabetes in Europe. Diabetologia 45: S5–12CrossRefPubMed
23.
go back to reference Olveira G, Olvera P, Carral F et al. (2004) Excess cost due to hospitalization of persons with diabetes in Andalucía (Spain). Diabetes Care 27: 1904–1909PubMed Olveira G, Olvera P, Carral F et al. (2004) Excess cost due to hospitalization of persons with diabetes in Andalucía (Spain). Diabetes Care 27: 1904–1909PubMed
24.
go back to reference Gilmer TP, O’Connor PJ, Manning WG, Rush WA (1997) The cost to health plans of poor glycemic control. Diabetes Care 20: 1847–1853PubMed Gilmer TP, O’Connor PJ, Manning WG, Rush WA (1997) The cost to health plans of poor glycemic control. Diabetes Care 20: 1847–1853PubMed
25.
go back to reference Wagner EH, Sandhu N, Newton KM et al. (2001) Effect of improved glycemic control on health care costs and utilization. JAMA 285: 182–189CrossRefPubMed Wagner EH, Sandhu N, Newton KM et al. (2001) Effect of improved glycemic control on health care costs and utilization. JAMA 285: 182–189CrossRefPubMed
26.
go back to reference Gray A, Raikou M, McGuire A et al. (2000) Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 320: 1373–1378CrossRefPubMed Gray A, Raikou M, McGuire A et al. (2000) Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 320: 1373–1378CrossRefPubMed
Metadata
Title
Economic cost associated with type II diabetes in Spanish patients
Authors
Miguel Ballesta
Florentino Carral
Gabriel Olveira
José Antonio Girón
Manuel Aguilar
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
The European Journal of Health Economics / Issue 4/2006
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-006-0367-9

Other articles of this Issue 4/2006

The European Journal of Health Economics 4/2006 Go to the issue